semaglutide and heart disease GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, Emerging Therapies Does Ozempic Help Your Heart?

9 The consensus statement from the American Association of Clinical Endocrinologists supports the use of GLP-1 RAs as first-line therapy in managing hyperglycaemia in T2D patients with established (or at high risk of) atherosclerotic CVD, as well as in those with chronic kidney disease or a history of stroke or transient ischaemic attack, while recommending the administration of sodiumglucose cotransporter 2 inhibitors to HF patients

The study authors said the results show significant reductions in exacerbation burden and reliever use, exposure to inhaled corticosteroids and pneumonia events, irrespective of whether the drugs were being used to treat obesity or type 2 diabetes

Customized doses may help patients respond better or manage side effects

Grass Fed